Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors
Author | Hammuda, Arwa |
Author | Shalaby, Raed |
Author | Rovida, Stefano |
Author | Edmondson, Dale E. |
Author | Binda, Claudi |
Author | Khalil, Ashraf |
Available date | 2021-09-01T10:03:33Z |
Publication Date | 2016 |
Publication Name | European Journal of Medicinal Chemistry |
Resource | Scopus |
Abstract | A novel series of substituted chalcones were designed and synthesized to be evaluated as selective human MAO-B inhibitors. A combination of either methylsulfonyl or trifluoromethyl substituents on the aromatic ketone moiety with a benzodioxol ring on the other end of the chalcone scaffold was investigated. The compounds were tested for their inhibitory activities on both human MAO-A and B. All compounds appeared to be selective MAO-B inhibitors with Ki values in the micromolar to submicromolar range. Molecular modeling studies have been performed to get insight into the binding mode of the synthesized compounds to human MAO-B active site. 2016 Elsevier Masson SAS. All rights reserved. |
Sponsor | This work was supported by internal grants (# QUST-CPH-FALL-14?15-9 and QUST-CPH-SPR-14/15-9 ) from the Office of Academic Research, Qatar University , Doha, Qatar. C.B. is member of the collaborative network within the COST Action CM1103, Structure-based drug design for diagnosis and treatment of neurological diseases . We are grateful to Professor Neal Castagnoli Jr. Professor Emeritus, Virginia Tech for providing the MMTP substrate. The 2D-NMR spectra were recorded by Professor Khalid Elsayed, University of Louisiana at Monroe, USA. |
Language | en |
Publisher | Elsevier Masson SAS |
Subject | 3 (2,3 dimethoxyphenyl) 1 [2 (trifluoromethyl)phenyl]prop 2 en 1 one 3 (2,3 dimethoxyphenyl) 1 [3 (trifluoromethoxy)phenyl]prop 2 en 1 one 3 (2,3 dimethoxyphenyl) 1 [3 (trifluoromethyl)phenyl]prop 2 en 1 one 3 (2,3 dimethoxyphenyl) 1 [4 (methylsulfonyl)phenyl]prop 2 en 1 one 3 (2,3 dimethoxyphenyl) 1 [4 (methylthio)phenyl)prop 2 en 1 one 3 (benzo[d][1,3]dioxol 4 yl) 1 [2 (trifluoromethyl)phenyl]prop 2 en 1 one 3 (benzo[d][1,3]dioxol 4 yl) 1 [3 (trifluoromethoxy)phenyl]prop 2 en 1 one 3 (benzo[d][1,3]dioxol 4 yl) 1 [3 (trifluoromethyl)phenyl]prop 2 en 1 one 3 (benzo[d][1,3]dioxol 4 yl) 1 [4 (methylsulfonyl)phenyl]prop 2 en 1 one amine oxidase (flavin containing) isoenzyme A amine oxidase (flavin containing) isoenzyme B aromatic compound chalcone derivative ketone monoamine oxidase B inhibitor unclassified drug amine oxidase (flavin containing) chalcone derivative monoamine oxidase inhibitor animal cell Article binding affinity binding site controlled study drug binding drug design drug potency drug screening drug selectivity drug structure drug synthesis enzyme inhibition hydrogen bond IC50 insect cell nonhuman chemical structure chemistry dose response human metabolism molecular docking structure activity relation synthesis Chalcones Dose-Response Relationship, Drug Drug Design Humans Molecular Docking Simulation Molecular Structure Monoamine Oxidase Monoamine Oxidase Inhibitors Structure-Activity Relationship |
Type | Article |
Pagination | 162-169 |
Volume Number | 114 |
Check access options
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Pharmacy Research [1314 items ]